Investing Center Preview – Manage your investments and watch your net worth grow.
MRK:NYSE – Large Cap Stock (Drug Manufacturers/Major)
Merck & Co Inc – MRK Stock Overview
|Last Price||Today's Change||52-Week Range||Trading Volume|
|58.82||0.03 (+0.05%)||45.69 - 60.07||6.3 million (Below Avg)|
Market data as of 4:00PM 07/22/16. Quotes are delayed by at least 15 min.
Overview - MRK
One-Click Scorecard - MRK
These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Performed well consistently?||Fail|
|Avoids excess debt?||Fail|
|Converting sales to profits?||Fail|
|Shareholder's money handled rationally?||Pass|
|Increased shareholder value?||Fail|
|Consistently increased owner earnings?||Fail|
|Sells at 25% discount to intrinsic value?||Fail|
These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
|Pays a cash dividend?||Pass|
|Room to increase dividends?||Fail|
|Increased earnings over time?||Fail|
|Borrows within reasonable limits?||Fail|
|Stock is undervalued?||Fail|
|Have investors caught on?||Fail|
|Has support of institutional investors?||Pass|
|Has sufficient liquidity?||Pass|
Latest Headlines - MRK
Data for Merck's Investigational Once-Daily Formulation of ISENTRESS® (raltegravir) Show That at Week 48, a Regimen Containing the Once-Daily Dosing Formulation...
Business Wire - Friday 07/22/2016 7:00 AM ET
Merck Animal Health Receives FDA Approval of BRAVECTO® (fluralaner topical solution) for Cats and Dogs
Business Wire - Thursday 07/21/2016 5:00 PM ET
Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent Bezlotoxumab
Business Wire - Thursday 07/21/2016 4:30 PM ET
Reorganization of electroCore management team as Frank Amato becomes CEO and founder JP Errico becomes Chief Science and Strategy Officer.
Business Wire - Thursday 07/21/2016 6:00 AM ET
Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vallée S.A.
Business Wire - Friday 07/01/2016 12:05 PM ET
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
Business Wire - Thursday 06/30/2016 8:31 AM ET
Covered Call reports for Micron, Baidu, Merck & Company Incorporated, Consol Energy and JetBlue include trade ideas that offer returns of 20% or more!
PR Newswire - Wednesday 06/29/2016 9:31 AM ET
Merck and Moderna Announce Strategic Collaboration to Advance Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA® (pembrolizumab) for the Treatment of Multiple Types of Cancer
Business Wire - Wednesday 06/29/2016 7:00 AM ET
Industry Position - MRK
|Revenue Growth (1yr)||-4.86%|
|Net Income Growth (1yr)||-58.50%|